Journal of Neurochemistry

Papers
(The H4-Index of Journal of Neurochemistry is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Microglial phagocytosis of neurons in neurodegeneration, and its regulation144
Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease111
Chrono‐nutrition: From molecular and neuronal mechanisms to human epidemiology and timed feeding patterns110
Exosomes in Parkinson disease83
Microbiota‐gut‐brain axis as a regulator of reward processes75
Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer’s disease64
Astrocytes are HIV reservoirs in the brain: A cell type with poor HIV infectivity and replication but efficient cell‐to‐cell viral transfer56
The role of neuroimaging in Parkinson’s disease54
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance54
Emerging role of PARP‐1 and PARthanatos in ischemic stroke50
Cellular and physiological functions of C9ORF72 and implications for ALS/FTD48
Iron, ferroptosis, and ischemic stroke44
Ferroptosis: An emerging therapeutic target in stroke43
Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species42
The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)42
Mislocalisation of TDP‐43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex41
Amyloid processing in COVID‐19‐associated neurological syndromes39
The multi‐functional RNA‐binding protein G3BP1 and its potential implication in neurodegenerative disease39
24S‐hydroxycholesterol: Cellular effects and variations in brain diseases38
Synaptophysin‐dependent synaptobrevin‐2 trafficking at the presynapse‐Mechanism and function38
Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide‐induced microglial and astrocytic neuroinflammation by increasing NAD+38
Regulators of cholinergic signaling in disorders of the central nervous system38
MicroRNA‐3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease37
Circuit selectivity in drug versus natural reward seeking behaviors36
Toll‐like receptor 2 activation and up‐regulation by high mobility group box‐1 contribute to post‐operative neuroinflammation and cognitive dysfunction in mice36
Hippocampal hyperactivity in a rat model of Alzheimer’s disease36
Milestone Review: Metabolic dynamics of glutamate and GABA mediated neurotransmission — The essential roles of astrocytes35
Addiction‐related neuroadaptations following chronic nicotine exposure35
Mass spectrometry‐based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids35
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders34
Microglia‐dependent remodeling of neuronal circuits34
Glucocorticoid‐mediated mechanisms of hippocampal damage: Contribution of subgranular neurogenesis32
Neuromuscular junction‐on‐a‐chip: ALS disease modeling and read‐out development in microfluidic devices32
0.10754108428955